In 1999, a group of interventional cardiologists got together in Norcross, Georgia with the goal to translate ideas for medical devices, biologics, and drugs into cutting-edge technologies. They collaborated with sponsors to test product designs and formulations and to train physicians, health professionals, and company representatives and ultimately formed Saint Joseph’s Translational Research Institute (SJTRI). Their mission was simple – to get medical devices and therapies to patients faster and safely with the hope of changing the face of modern medicine.
By 2009, SJTRI, as part of the Saint Joseph’s Health System (SJHS), had expanded to over 35 employees in a multi-million dollar facility with full-equipped operating rooms, wet labs, and office space. In 2012, SJHS entered into a partnership with Emory Healthcare in which Emory acquired majority ownership. Recently, they changed their name to T3 Labs or Translational Testing and Training Laboratories, Inc. T3 Labs manages studies in a number of fields, including cardiovascular, orthopedic, urology, and regenerative medicine. With Emory, they are working to streamline pre-clinical device development cycles and leverage the expertise of both industry and academia. By partnering with Emory, T3 Labs has the ability to function as a private institution with its industry sponsors while simultaneously offering advantages to its sponsors only a research institution can provide. Unsurprisingly, we are excited to work with this valuable resource of the Emory University system to help further medical devices to patients in need.